SET Nuclear Oncogene (SET) (N-Term) Peptid
SET
Wirt: Synthetic
BP, IHC, WB, IP
Produktnummer ABIN8111551
168,15 €
Zzgl. Versandkosten 20,00 € und MwSt
100 μg
Lieferung nach:
Deutschland
Lieferung in 6 bis 9 Werktagen
Kurzübersicht für SET Nuclear Oncogene (SET) (N-Term) Peptid (ABIN8111551)
Target
SET/TAF-I (SET)
(SET Nuclear Oncogene (SET))
Quelle
Synthetic
Applikation
Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB), Immunoprecipitation (IP)
-
-
Protein Region
- N-Term
-
Verwendungszweck
- SET Peptide - N-terminal region
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti-SET antibody ( ARP56542_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- SET/TAF-I (SET) (SET Nuclear Oncogene (SET))
-
Hintergrund
-
Background Information: SET is a multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone binding. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-indu
Alternative Symbols: 2PP2A, I2PP2A, IGAAD, PHAPII, TAF-IBETA, TAF-I, IPP2A2
-
Molekulargewicht
- 32kDa
-
Gen-ID
- 6418
-
NCBI Accession
- NP_003002
-
UniProt
- B2RCX0
Target
-
Sie sind hier:
